title: Modifying sunitinib schedule in advanced kidney cancer patients: Reflections from the results of the renal EFFECT trial.
authors.affiliation: Medical Oncology, I.R.C.C.S. San Matteo University Hospital Foundation, Pavia, Italy, and Italian Nephro-Oncology Group/Gruppo Italiano di Oncologia Nefrologica (G.I.O.N.), Pavia, Italy.
authors.forename: Camillo
authors.initials: C
authors.lastname: Porta
authors.affiliation: Medical Oncology, I.R.C.C.S. San Matteo University Hospital Foundation, Pavia, Italy, and Italian Nephro-Oncology Group/Gruppo Italiano di Oncologia Nefrologica (G.I.O.N.), Pavia, Italy.
authors.forename: Carlo
authors.initials: C
authors.lastname: Ganini
authors.affiliation: Medical Oncology, I.R.C.C.S. San Matteo University Hospital Foundation, Pavia, Italy, and Italian Nephro-Oncology Group/Gruppo Italiano di Oncologia Nefrologica (G.I.O.N.), Pavia, Italy.
authors.forename: Chiara
authors.initials: C
authors.lastname: Paglino
references.citation: Cancer Chemother Pharmacol. 2010 Jul;66(2):357-71
references.pmid: 19967539
references.citation: N Engl J Med. 2007 Jan 11;356(2):115-24
references.pmid: 17215529
references.citation: Br J Cancer. 2008 Jul 22;99(2):259-65
references.pmid: 18594533
references.citation: J Clin Oncol. 2012 Apr 20;30(12 ):1371-7
references.pmid: 22430274
references.citation: Clin Cancer Res. 2009 Apr 1;15(7):2497-506
references.pmid: 19258444